Liver Disease: Clinical Trials

8 trials for Liver Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 terminated. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 5, Unknown 2, Terminated 1
Phase 21Unknown 1

Follow Liver Disease: new trials by email Literature Review of Liver Disease trials Research Report on Liver Disease

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)
HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate), Hepatic Venous Pressure Gradient (HVPG) - Liver Disease
Phase 3CompletedUniversity of Colorado, Denver202016-03-012021-08-09
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
18F- fluorocholine, 18F- fluorodeoxyglucose - Hepatocellular Carcinoma, Liver Disease
Phase 3UnknownNational Taiwan University Hospital1502014-02-012014-02-28
Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy
indocyanine green fluorescent cholangiography, methylene blue - Liver Disease
Phase 3CompletedCentre Hospitalier Universitaire, Amiens1502013-07-082025-07-23
Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection
Preoperative Gabexate Mesilate group, Intraoperative Gabexate Mesilate group, hepatectomy with dextrose water - Liver Disease
Phase 3TerminatedYonsei University22012-02-242018-07-18
Remote Ischemic Preconditioning In Abdominal Organ Transplantation
RIPC by Inflation of Pneumatic Tourniquet - Kidney Disease, Liver Disease
Phase 3CompletedUniversity of Medicine and Dentistry of New Jersey852009-04-012015-01-14
Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir
Entecavir - Liver Transplantation, Hepatitis B
Phase 3CompletedHepNet Study House, German Liverfoundation202008-03-012014-11-05
Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
Vaccination with VZV vaccine - Liver Disease, Immunosuppression
Phase 2 / Phase 3UnknownUniversity Hospital, Geneva802007-06-012020-09-18
Gabapentin to Treat Itch in Patients With Liver Disease
Gabapentin, Placebo - Liver Disease, Cholestasis
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)152000-11-012017-10-13

Narrower conditions

Liver Diseases (8)  ·  Biliary Fistula (1)  ·  Carcinoma, Hepatocellular (1)  ·  Chickenpox (1)  ·  Cholestasis (1)  ·  Delayed Graft Function (1)  ·  Fibrosis (1)  ·  Hepatitis (1)  ·  Hepatitis B (1)  ·  Kidney Diseases (1)  ·  Pancreatic Diseases (1)  ·  Postoperative Complications (1)  ·  Pruritus (1)  ·  Reperfusion Injury (1)

Broader conditions

Digestive System Diseases (8)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Pathologic Processes (3)  ·  DNA Virus Infections (2)  ·  Infections (2)  ·  Virus Diseases (2)  ·  Adenocarcinoma (1)  ·  Bile Duct Diseases (1)  ·  Biliary Tract Diseases (1)  ·  Blood-Borne Infections (1)  ·  Carcinoma (1)  ·  Cardiovascular Diseases (1)  ·  Communicable Diseases (1)  ·  Digestive System Fistula (1)  ·  Digestive System Neoplasms (1)

Interventions

Fluorodeoxyglucose F18 (1)  ·  Gabapentin (1)  ·  Hepatectomy (1)  ·  Methylene Blue (1)  ·  Pharmaceutical Preparations (1)  ·  Vaccination (1)  ·  entecavir (1)  ·  fluorocholine (1)

Sponsors

Centre Hospitalier Universitaire, Amiens (1)  ·  HepNet Study House, German Liverfoundation (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  National Taiwan University Hospital (1)  ·  University Hospital, Geneva (1)  ·  University of Colorado, Denver (1)  ·  University of Medicine and Dentistry of New Jersey (1)  ·  Yonsei University (1)

Countries

United States (3)  ·  France (1)  ·  Germany (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  Taiwan (1)

Top investigators

Amanda Wieland, MD (1)  ·  Baburao Koneru, M.D. (1)  ·  Heiner Wedemeyer, MD (1)  ·  Kai-Yuan Tzen, MD (1)  ·  Klara M Posfay-Barbe, MD, MS (1)  ·  Michael P Manns, MD (1)  ·  Nora V Bergasa, M.D. (1)

Results publications

PMID 17058231, PMID 22030902

NIH funding

2008 (1), R03DK055618 (1), UL1TR001082 (1)